The Howard County Board of Education is taking legal action against a group of Big Pharma companies, including heavyweights Eli Lilly, Sanofi, Novo Nordisk, UnitedHealth Group, and several CVS Health subsidiaries. In a bold move to combat the surge in insulin prices, the school board filed a lawsuit accusing these entities of engaging in a pricing scheme that has led to a significant rise in the cost of insulin over the years, despite minimal changes to the drug itself. According to a report by The Daily Record, the Howard County Public School System, which offers a health insurance plan to its employees, has overpaid for the life-saving drug since 2010.
According to information from the lawsuit obtained by SUN, the cost of some diabetes medications has increased over 10-fold in the last two decades, a stark contrast to the 1.75-fold rise in the average cost of consumer goods and services. The Board of Education asserts that this increase has detrimental effects on its budget, consequently hindering its ability to serve the community. It emphasizes that the price hikes are not attributed to rises in production costs or investments in research and development, but rather, are a result of manipulation by the defendants for profit.
Adding to their allegations, the board accuses pharmacy benefit managers, such as CVS Caremark, Express Scripts, and OptumRx, of colluding with the drug manufacturers. These managers play a crucial role in establishing formularies, which are lists of approved medications, and they determine coverage for diabetes medications. These managers are also part of the lawsuit, as they hold more than 80% of the market and are operated by the same entities that own three of the largest insurance companies in the US.
Spokespeople for Lilly and Sanofi have rejected the accusations. "These copycat lawsuits are baseless," a Lilly spokesperson stated, in a statement echoed by Sanofi, "While we will not comment on the specifics of the allegations, Sanofi's pricing practices have always complied with the law and the company is committed to helping patients access the medicine they need at the lowest possible price." The Daily Record initially reported both statements. The lawsuit raises serious concerns about pricing practices within the pharmaceutical industry and their impact on payors, such as the Howard County Board of Education. It is a developing story that threatens to shake up the current status quo of drug pricing in the United States.
